The market is expected to trade with a positive bias, albeit within a likely rangebound zone. Below are some short-term trading ideas to consider.

Trade Spotlight: How should you trade Steel Strips Wheels, Honasa Consumer, Bharat Electronics, UPL, GSK Pharma, and others on May 5?

Benchmark indices may once again attempt to test the previous day's highs, but sustaining those levels is the key to watch amid ongoing consolidation. Below are some short-term trading ideas to consider.

Market turning around? 3 stock picks backed by multi-timeframe analysis

Rather than solely betting on a bounce or trend reversal in the broader index, look to stocks like Castrol India, Cholamandalam Investment, and GlaxoSmithKline that demonstrate potential bullish signals across multiple timeframes.

Top 10 trading ideas for next 3-4 weeks as market melts in bear hug

If the Nifty50 holds current levels and surpasses 17,200-17,300 in coming sessions, then 17,500 can be a possible target with crucial support at 17,000 followed by 16,800-16,750 levels

Hot Stocks | Here is why you should bet on Adani Ports, Glaxo Pharma, Nalco for short term

The lower high lower and low formation will be neglected only above 17,600 levels till then, this can be considered as a short-term pullback

Market rebounds after 3-month low: Top 10 trading ideas by experts for next 3-4 weeks

Traders can continue with a stock specific approach. "And we may see trades on both sides if Nifty remains in a consolidation mode," says Sameet Chavan of Angel One.

Market at 3-month low. Top 10 trading ideas for the December series

Experts feel the mood at street turned more cautious and nervous after Friday's sharp fall and hence the more correction can't be ruled out if the Nifty decisively breaks 17,000 mark in coming days.

Build your diversified and secured Rs 1 crore portfolio in Samvat 2077 by investing in these 13 stocks

If you are a retail investor have Rs 1 crore to invest, here are a few recommendations for investing and dividing your portfolio exposure across these sectors.

Hot Stocks | Glaxo Pharma, M&M, Tata Comm three buy ideas for short term

Use this sharp correction to accumulate long positons with SL of 8900 immediate resistance is seen around 9400 levels.

Hot Stocks | Three stock ideas for the short term

By surpassing the resistance of 8,600 in the previous week, Nifty also confirmed the bullish inverse head and shoulder pattern breakout on the daily line charts.

Dharmesh Shah sees Nifty heading towards its record high of 12,100, bets on these 2 stocks

We expect the index to maintain positive bias and challenge its record high of 12,100 in coming sessions

Hold GlaxoSmithKline Pharmaceuticals, says Avinnash Gorakssakar

According to Avinnash Gorakssakar, Market Expert, one may hold GlaxoSmithKline Pharmaceuticals

Hold GlaxoSmithKline Pharmaceuticals: Prakash Gaba

Prakash Gaba of prakashgaba.com is of the view that one may hold GlaxoSmithKline Pharmaceuticals.

HUL, CG Consumer Electrical hit fresh 52-week high post GST Council meet outcome

Consumer and light electric companies hit fresh 52-week high after the Goods and Services Tax (GST) Council on Friday decided to slash rates on more than 175 items, reducing taxes on these from the existing 28 percent.

Trusted 30: FIIs, DIIs, and LIC see value in these stocks which rose up to 140% in 2017

The idea behind creating ‘wealth’ is to find companies which can outperform benchmark indices in a Bull Run and contain damage when the equity markets decide to head south.

Hold GSK Pharma, says Prakash Gaba

Prakash Gaba of prakashgaba.com is of the view that one may hold GlaxoSmithKline Pharmaceuticals.

Tulsian's take on ICICI Pru Life listing, MRF & other tyre shrs

SP Tulsian of sptulsian.com tells CNBC-TV18 why he would not give a buy call on MRF stock which touched Rs 50,000-mark in trade Wednesday. He also shares his take on other tyre stocks.

Cut target on GSK Pharma, see gradual recovery: Credit Suisse

With maintaining neutral rating on Glaxosmithkline Pharmaceutical, Credit Suisse slashed target price to Rs 2,850 as it continues to struggle with price control & supply constraints in some products. It also reduced FY17 earnings per share by 41 percent.

Houseviews: Analysts bet on 7 largecaps, 5 midcaps for profit

Credit Suisse says GST is a major negative for alcohol companies as they are kept out of GST and earnings could get hit by 15-20 percent in FY18. It says input cost inflation could hit margin by 150-200 basis points. Input taxes on raw materials may become stranded with no offsets.

Stay invested in GSK Pharma: Harendra Kumar

According to Harendra Kumar of Elara Capital, one may stay invested in GlaxoSmithKline Pharmaceuticals.

Bullish on Lupin, Aurobindo; cautious on Ranbaxy: Religare

Arvind Bothra, vice president of institutional research at Religare Capital Markets is cautious on Ranbaxy because the earnings visibility is very low and believes that the expectations of a turnaround in the US business etc are seemingly priced-in the stock.

Hold GlaxoSmithKline Pharma: Ambareesh Baliga

Ambareesh Baliga of Edelweiss Financial Services is of the view that one may hold GlaxoSmithKline Pharmaceuticals as the stock may head higher.

Subscribe to GSK Pharma open offer: Ajay Srivastava

Ajay Srivastava, CEO at Dimensions Consulting suggests to the open offer of GlaxoSmithKline Pharmaceuticals. "One may buy it around Rs 2600-2700," he adds.

GSK Pharma may rally to Rs 2880-2900: SP Tulsian

GSK Pharma may rally to Rs 3000 in next two- three months, says SP Tulsian of sptulsian.com.

Buy Britannia, GSK Pharma; sell HDIL, SAIL: Parag Doctor

Parag Doctor of Keynote Capital recommended buying Britannia Industries and Glaxosmithkline Pharma. However, he advised one can sell HDIL and SAIL.